SANDERS CHARLES A

CIK 000102293610 companiesDANBURY, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001022936

Recent Transactions

50 trades

Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2016-02-29$1.99/sh+4,396→ 12,971 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2015-11-30$10.61/sh+824→ 8,575 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2015-08-31$11.64/sh+751→ 7,751 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2015-05-20+15,000→ 15,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2013-05-31+15,000→ 15,000 total
Conversion
LIPOSCIENCE INC
Series E Convertible Preferred Stock
2013-01-30−2,298→ 0 total
Conversion
LIPOSCIENCE INC
Common Stock
2013-01-30+1,114→ 9,844 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2012-05-23+15,000→ 15,000 total
Purchase
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2012-03-13$5.20/sh+2,000→ 7,000 total
Purchase
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2012-03-13$5.21/sh+2,000→ 7,000 total
Award
ALBIREO PHARMA, INC.
Stock Option (right to buy)
2012-03-08+20,000→ 20,000 total
Exercise/Conversion
ALBIREO PHARMA, INC.
Restricted Stock Unit
2011-09-30−3,937→ 0 total
Exercise/Conversion
ALBIREO PHARMA, INC.
Common Stock
2011-09-30+3,937→ 19,096 total
Disposition from Tender
ICAGEN INC
Common Stock
2011-09-02$6.00/sh−25,657→ 0 total
Exercise/Conversion
ICAGEN INC
Common Stock
2011-09-01$3.36/sh+3,750→ 17,907 total
Exercise/Conversion
ICAGEN INC
Director Stock Option (right to buy)
2011-09-01−3,750→ 0 total
Exercise/Conversion
ICAGEN INC
Director Stock Option (right to buy)
2011-09-01−3,750→ 0 total
Exercise/Conversion
ICAGEN INC
Director Stock Option (right to buy)
2011-09-01−4,000→ 0 total
Exercise/Conversion
ICAGEN INC
Common Stock
2011-09-01$2.56/sh+4,000→ 25,657 total
Exercise/Conversion
ICAGEN INC
Common Stock
2011-09-01$4.08/sh+3,750→ 21,657 total
Purchase
ALBIREO PHARMA, INC.
Common Stock
2011-08-10$1.16/sh+10,000→ 15,159 total
Award
ICAGEN INC
Director Stock Option (right to buy)
2011-06-03+4,000→ 4,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Non-Qualified Stock Option
2011-05-12+15,000→ 15,000 total
Award
ALBIREO PHARMA, INC.
Restricted Stock Units
2010-10-01+3,937→ 3,937 total
Award
ICAGEN INC
Director Stock Option (right to buy)
2010-06-04+30,000→ 30,000 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option
2010-06-01+40,000→ 40,000 total
Award
CEPHALON INC
Non-Qualified Stock Option
2010-05-20+15,000→ 15,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Non-Qualified Stock Option
2010-05-13+15,000→ 15,000 total
Purchase
ALBIREO PHARMA, INC.
Common Stock
2010-05-11$5.59/sh+5,000→ 5,159 total
Award
ALBIREO PHARMA, INC.
Stock Option (right to buy)
2010-03-02+20,000→ 20,000 total
Purchase
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2010-02-08$6.66/sh+5,000→ 5,000 total
Award
ICAGEN INC
Common Stock
2010-01-01+29,724→ 113,261 total
Exercise/Conversion
ICAGEN INC
Director Stock Option (right to buy)
2009-12-17+2,396→ 0 total
Exercise/Conversion
ICAGEN INC
Common Stock
2009-12-17$0.50/sh+2,396→ 83,537 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Automatic Stock Option Grant
2009-12-08$6.70/sh+8,333→ 8,333 total
Award
ICAGEN INC
Director Stock Option (right to buy)
2009-06-03+30,000→ 30,000 total
Award
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option
2009-06-01+40,000→ 40,000 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2009-05-18$10.05/sh+3,333→ 29,716 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option
2009-05-18−3,333→ 0 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2009-05-18$28.44/sh−3,333→ 26,383 total
Award
CEPHALON INC
Non-Qualified Stock Option
2009-05-12+10,000→ 10,000 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option
2009-05-11−3,333→ 3,333 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2009-05-11$30.41/sh−3,333→ 26,383 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2009-05-11$10.05/sh+3,333→ 29,716 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2009-05-04$10.05/sh+3,334→ 29,717 total
Exercise/Conversion
VERTEX PHARMACEUTICALS INC / MA$VRTX
Stock Option
2009-05-04−3,334→ 6,666 total
Sale
VERTEX PHARMACEUTICALS INC / MA$VRTX
Common Stock
2009-05-04$30.08/sh−3,334→ 26,383 total
Disposition to Issuer
GENENTECH INC
Common Stock
2009-03-26$95.00/sh−2,000→ 0 total
Disposition to Issuer
GENENTECH INC
Non-Qualified Stock Option (right to buy)
2009-03-26−20,000→ 0 total
Disposition to Issuer
GENENTECH INC
Non-Qualified Stock Option (right to buy)
2009-03-26−8,000→ 0 total

SANDERS CHARLES A

Recent Transactions

Companies

Recent Filings

Address